Empresa Alliqua Biomedical Inc Nasdaq
Acciones
US0196213096
Biotecnología e investigación médica
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Julien Mamet
FOU | Founder | - | 01/10/07 |
Rick Orr
CEO | Chief Executive Officer | - | 01/12/10 |
Dina Gonzalez
DFI | Director of Finance/CFO | - | 01/01/10 |
William Martin
PRN | Corporate Officer/Principal | - | 01/01/12 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Eckard Weber
BRD | Director/Board Member | 73 | - |
Stanley Abel
BRD | Director/Board Member | - | 01/01/08 |
Dennis Podlesak
CHM | Chairman | 66 | - |
Rick Orr
CEO | Chief Executive Officer | - | 01/12/10 |
Matthew Ruth
BRD | Director/Board Member | - | 06/05/19 |
Julien Mamet
FOU | Founder | - | 01/10/07 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 5 807 877 | 5 807 877 ( 100,00 %) | 0 | 100,00 % |
Información de la empresa
Adynxx, Inc.
100 Pine Street Suite 500
94111, San Francisco
+
Sector
Varia. 1 de ene. | Capi. | |
---|---|---|
+0,14 % | 42,19 mil M | |
+44,30 % | 40,15 mil M | |
-6,20 % | 28,31 mil M | |
+5,60 % | 24,63 mil M | |
-23,19 % | 18,2 mil M | |
+27,82 % | 12,01 mil M | |
-2,67 % | 11,76 mil M | |
+14,62 % | 10,4 mil M | |
-5,29 % | 9936,09 M |